Cells from all replicates were combined for further analyses
The 0.9% balances efficacy and safety
Despite the early termination of the trial, it is interesting to note that 13 of 140 patients had a median duration of response of 10.2 months, indicating that these patients benefited from combination therapy and that exploring the mechanisms of this benefit should be the focus of future research
Lee R, El-Massry A, El-Massry Y, Randleman JB
By attaching an acetyl group to the sulfur atom of cysteine within the glutathione tripeptide, SAG resists enzymatic degradation in the gastrointestinal tract, crosses cell membranes intact, and is then hydrolyzed intracellularly by cytoplasmic thioesterases to release free, bioactive GSH directly inside cells